OncorMed Incorporated

Oncormed, Inc. is a genomics services company that characterizes newly discovered genes to establish their medical relevance and provides molecular profiling of patients for pharmacogenomic and therapeutic purposes. The Company's mission is to accelerate the translation of cancer-related genetic discoveries into clinically-useful products and services through strategic collaborations with pharmaceutical, genomic and biotechnology companies.

Contact Details: 205 Perry Parkway Gaithersburg MD 20877 United States of America Tel: 301 208 1888 Fax: 301 926 6125 Email:

Loading...

OncorMed Incorporated Patents:
US Patent No.	Title
6083698	Cancer susceptibility mutations of BRCA1
6051379	Cancer susceptibility mutations of BRCA2
5756294	Susceptibility mutation for breast and ovarian cancer
5750400	Coding sequences of the human BRCA1 gene
5654155	Consensus sequence of the human BRCA1 gene
→View more OncorMed Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 664 times since April 2007, the link to the organisation's website has been followed 0 times

Recent Search Terms used to find this page: OncorMed company profile | Oncormed 205 Perry Pkwy. | OncorMed company profile | oncormed | .

Search for more companies in Gaithersburg

Search for more companies in MD

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for OncorMed Incorporated